Received Aug 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
Late 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 18-year-old female patient who did not receive Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (patient had 1st dose on 1st August 2022). The patient did not receive the 2nd dose of Bexsero, the patient experienced incomplete course of vaccination (Verbatim: Late 2nd dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-AUG-2025 Reporter just had a question about Bexsero. They had a pt who got 1 dose on 1st August 2022. Had too much time passed to give the 2nd dose. Till the time of reporting patient did not receive 2nd dose of Bexsero, which led to incomplete course of vaccination.